LivaNova (LIVN) Non-Current Debt (2015 - 2026)
LivaNova (LIVN) reported Non-Current Debt of $285.3 million for Q1 2026, down 54.58% on a YoY basis from $628.2 million in Q1 2025, and down 24.15% sequentially from $376.1 million in Q4 2025.
LivaNova (LIVN) Non-Current Debt (2015 - 2026) Analysis & Trends
LivaNova (LIVN) has 12 years of Non-Current Debt data on file, last reported at $285.3 million in Q1 2026.
- For the quarter ending Q1 2026, Non-Current Debt fell 54.58% year-over-year to $285.3 million; the trailing twelve-month figure through Mar 2026 stood at $285.3 million (down 54.58% YoY), and the FY2025 full-year result was $376.1 million, down 40.02% from the prior year.
- Non-Current Debt fell to $285.3 million in Q1 2026, from $376.1 million in the prior quarter.
- In the past five years, Non-Current Debt ranged from a high of $628.2 million in Q1 2025 to a low of $285.3 million in Q1 2026.
- A 5-year average of $510.8 million and a median of $541.8 million in 2023 frame the typical range for Non-Current Debt.
- Across the five-year window, Non-Current Debt jumped 129.09% in 2022 and plunged 54.58% in 2026, its largest moves.
- Tracing LIVN's Non-Current Debt over 5 years: stood at $518.1 million in 2022, then rose by 13.11% to $586.0 million in 2023, then grew by 7.0% to $627.0 million in 2024, then sank by 40.02% to $376.1 million in 2025, then fell by 24.15% to $285.3 million in 2026.
- Business Quant data shows LIVN's Non-Current Debt at $285.3 million in Q1 2026, $376.1 million in Q4 2025, and $349.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 29.64 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 14.22 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 26.17 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 10.99 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 598.50 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 8.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 10.13 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 3.18 Bn |
| 10 | LivaNova | 4.30 Bn | 3.76 Bn | 243.75 Mn | 285.28 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 285.28 Mn |
| Dec 31, 2025 | 376.10 Mn |
| Sep 30, 2025 | 349.03 Mn |
| Jun 30, 2025 | 348.49 Mn |
| Mar 31, 2025 | 628.15 Mn |
| Dec 31, 2024 | 627.00 Mn |
| Sep 30, 2024 | 604.29 Mn |
| Jun 30, 2024 | 605.43 Mn |
| Mar 31, 2024 | 604.75 Mn |
| Dec 31, 2023 | 586.00 Mn |
| Sep 30, 2023 | 568.16 Mn |
| Jun 30, 2023 | 586.40 Mn |
| Mar 31, 2023 | 541.76 Mn |
| Dec 31, 2022 | 518.07 Mn |
| Sep 30, 2022 | 537.00 Mn |
| Jun 30, 2022 | 459.79 Mn |
| Mar 31, 2022 | 457.54 Mn |
| Dec 31, 2021 | 236.80 Mn |
| Sep 30, 2021 | 234.41 Mn |
| Jun 30, 2021 | 431.03 Mn |